HCA is the ticker symbol for HCA Healthcare, Inc., a publicly traded Healthcare sector company listed on NYSE. 13F Pro tracks HCA with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is HCA a good stock to buy?

13F Pro's AI ranking engine scores HCA at 67.5/100, ranked #362 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for HCA is available at https://13fpro.ai/company/HCA. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source HCA data?

All HCA Healthcare, Inc. fundamentals and ownership data come directly from SEC EDGAR. HCA Healthcare, Inc. files with the SEC under CIK 860730. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

HCA Healthcare, Inc. HCA

NYSELarge CapHealthcare

13F Pro quality score

Rank #362 of 2,925TOP 25%

Why it scores 68 Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$20.23B

Quarter to Jun 30

Net income

$1.70B

Quarter to Jun 30

Free cash flow

$1.10B

Quarter to Jun 30

Operating margin

12.3%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026

$51.25B total

BlackRock, Inc.

$5.07B-2.7%

VANGUARD CAPITAL MANAGEMENT LLC

$3.95B-0.4%

Sanders Capital, LLC

$3.44B-1.4%

STATE STREET CORP

$2.91B-0.9%

WELLINGTON MANAGEMENT GROUP LLP

$1.84B+20.5%

GEODE CAPITAL MANAGEMENT, LLC

$1.42B-0.7%

First Eagle Investment Management, LLC

$1.28B+1.3%

VANGUARD PORTFOLIO MANAGEMENT LLC

$1.06B-1.6%

MORGAN STANLEY

$1.01B+12.7%

GOLDMAN SACHS GROUP INC

$960.81M+15.4%

JPMORGAN CHASE & CO

$896.80M-7.2%

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

$861.46M+2.0%

NORGES BANK

$836.46M--

Capital World Investors

$770.86M+0.2%

Capital International Investors

$747.40M-36.8%

NORTHERN TRUST CORP

$666.15M-2.5%

FMR LLC

$636.50M-62.9%

Invesco Ltd.

$596.39M+6.3%

NORDEA INVESTMENT MANAGEMENT AB

$553.70M-1.2%

BARCLAYS PLC

$514.35M+5.7%

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME

$485.25M-17.0%

Crake Asset Management LLP

$449.07MNew

Metropolis Capital Ltd

$430.92M+195.3%

Darsana Capital Partners LP

$428.88M+46.7%

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

$414.57M-0.8%

See all 1,344 institutional holders →

What's Driving HCA's Business? Latest 10-Q Breakdown

43/43 datapoints verified

AI-extracted from the 10-Q filed 2026-07-28 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenues rose 8.7% to $20.230B, but $1.372B of incremental Florida Medicaid directed payment revenue — $980M tied to prior periods — flattered the quarter.

Biggest Revenue Drivers

Atlantic Group$7,573M

Florida-heavy group; adjusted segment EBITDA rose to $1,827M from $1,352M

American Group$6,582M

Adjusted segment EBITDA declined to $1,369M from $1,578M

Biggest Revenue Drivers

Total revenue: $20.230B+8.7% YoY

Atlantic Group$7,573M

Florida-heavy group; adjusted segment EBITDA rose to $1,827M from $1,352M

American Group$6,582M

Adjusted segment EBITDA declined to $1,369M from $1,578M

National Group$5,251M

Adjusted segment EBITDA declined to $1,184M from $1,271M

Corporate and other$824M

Includes the seven hospitals operated in England

Largest Expense Items

Salaries and benefits$8,290M41.0% of revenues vs 43.7%

Salaries and benefits per equivalent admission declined 0.7%; same facility per full-time equivalent rose 2.5%

Other operating expenses$5,043M24.9% of revenues vs 20.4%

Primarily growth in Medicaid state directed and supplemental payment program expenses and professional fees

Supplies$2,886M14.3% of revenues vs 15.3%

Supply cost per equivalent admission declined 1.0%; pharmacy supplies down 5.0% on lower drug utilization

Depreciation and amortization$944M+$81M YoY

Increase relates primarily to capital expenditures at existing facilities

Margins: Income before income taxes fell to 12.3% of revenues from 13.0%. Lower salaries (41.0% vs 43.7%) and supplies (14.3% vs 15.3%) ratios were more than offset by other operating expenses at 24.9% vs 20.4%.

Watch Items from the Filing

Q2 included $1.372B incremental revenues and $829M other operating expenses from the Florida directed payment program; ~$980M of revenues related to periods prior to 2026.
Consolidated uninsured admissions rose 23.3% after enhanced premium tax credits expired; estimated cost of uncompensated care rose to $1.445B from $1.116B.
103 hospitals in Texas and Florida generated 58% of admissions and 55% of revenues, and 73% of uninsured admissions.
Managed care and insurers revenue fell to $9,013M from $9,124M, unfavorably impacted by EPTC expiration and Exchange administrative reforms.
Debt totaled $49.718B with quarterly interest expense of $599M; second-quarter operating cash flow fell $1.875B to $2.335B on Medicaid receivables and tax timing.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Debt/Equity

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/HCA

Earnings Per Share

13fpro.ai/company/HCA

Loading ratio trend…

HCA Healthcare, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$75.6B	$6.8B	13.0%
FY 2024	10-K	$70.6B	$5.8B	12.1%
FY 2023	10-K	$65.0B	$5.2B	11.9%
FY 2022	10-K	$60.2B	$5.6B	14.2%
FY 2021	10-K	$58.8B	$7.0B	16.7%
FY 2020	10-K	$51.5B	$3.8B	10.5%

About HCA Healthcare, Inc. (HCA): stock profile, AI score and financials

HCA Healthcare, Inc. (HCA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCA at 67.5/100 on a composite quality score built from its SEC filings, placing it at rank #362 of 2,925 stocks — the top 25% of the AI-ranked universe. HCA scores in the top quartile across revenue scale (97.9), balance sheet strength (87.3), earnings quality (77.9). Based on the latest XBRL financial filings (Q2 2026), HCA Healthcare, Inc. reports quarterly revenue of $20.2B, net income of $1.7B, an operating margin of 12.3%. Top institutional holders of HCA by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, Sanders Capital, based on the most recent SEC filings. HCA trades on the NYSE exchange and files with the SEC under CIK 860730. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HCA Healthcare, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 860730 →

HCA Healthcare, Inc. HCA

Top Institutional Holders

What's Driving HCA's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Biggest Revenue Drivers

Largest Expense Items

Watch Items from the Filing

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

HCA key financials by period

HCA insiders

Congress trading in HCA

About HCA Healthcare, Inc. (HCA): stock profile, AI score and financials

HCA Healthcare, Inc. HCA

Top Institutional Holders

What's Driving HCA's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

HCA key financials by period

Companies similar to HCA

HCA insiders

Congress trading in HCA

About HCA Healthcare, Inc. (HCA): stock profile, AI score and financials